Annual EBIT
-$190.65 M
-$58.51 M-44.28%
December 31, 2023
Summary
- As of February 26, 2025, CGEM annual earnings before interest & taxes is -$190.65 million, with the most recent change of -$58.51 million (-44.28%) on December 31, 2023.
- During the last 3 years, CGEM annual EBIT has fallen by -$130.31 million (-215.98%).
- CGEM annual EBIT is now -522226.03% below its all-time high of -$36.50 thousand, reached on December 1, 2008.
Performance
CGEM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$48.85 M
+$1.17 M+2.34%
September 30, 2024
Summary
- As of February 26, 2025, CGEM quarterly earnings before interest & taxes is -$48.85 million, with the most recent change of +$1.17 million (+2.34%) on September 30, 2024.
- Over the past year, CGEM quarterly EBIT has stayed the same.
- CGEM quarterly EBIT is now -3660.86% below its all-time high of $1.37 million, reached on March 31, 2021.
Performance
CGEM Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$187.36 M
-$4.05 M-2.21%
September 30, 2024
Summary
- As of February 26, 2025, CGEM TTM earnings before interest & taxes is -$187.36 million, with the most recent change of -$4.05 million (-2.21%) on September 30, 2024.
- Over the past year, CGEM TTM EBIT has stayed the same.
- CGEM TTM EBIT is now -6922.37% below its all-time high of $2.75 million, reached on March 1, 2019.
Performance
CGEM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CGEM EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -44.3% | 0.0% | 0.0% |
| 3 y3 years | -216.0% | 0.0% | 0.0% |
| 5 y5 years | -1207.1% | 0.0% | 0.0% |
CGEM EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -180.6% | at low | -64.1% | +22.1% | -175.7% | +1.7% |
| 5 y | 5-year | -756.1% | at low | -3660.9% | +22.1% | -5224.1% | +1.7% |
| alltime | all time | <-9999.0% | at low | -3660.9% | +22.1% | -6922.4% | +1.7% |
Cullinan Oncology EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$48.85 M(-2.3%) | -$187.36 M(+2.2%) |
| Jun 2024 | - | -$50.03 M(+16.4%) | -$183.30 M(+7.3%) |
| Mar 2024 | - | -$42.99 M(-5.5%) | -$170.88 M(-10.4%) |
| Dec 2023 | -$190.65 M(+44.3%) | -$45.48 M(+1.5%) | -$190.65 M(+7.2%) |
| Sep 2023 | - | -$44.80 M(+19.1%) | -$177.77 M(+9.2%) |
| Jun 2023 | - | -$37.60 M(-40.1%) | -$162.74 M(+0.3%) |
| Mar 2023 | - | -$62.76 M(+92.5%) | -$162.24 M(+22.8%) |
| Dec 2022 | -$132.14 M(+94.5%) | -$32.61 M(+9.5%) | -$132.14 M(-1.3%) |
| Sep 2022 | - | -$29.77 M(-19.8%) | -$133.88 M(+9.3%) |
| Jun 2022 | - | -$37.11 M(+13.6%) | -$122.48 M(+20.1%) |
| Mar 2022 | - | -$32.66 M(-4.9%) | -$101.98 M(+50.1%) |
| Dec 2021 | -$67.95 M(+12.6%) | -$34.35 M(+86.9%) | -$67.95 M(+8.2%) |
| Sep 2021 | - | -$18.38 M(+10.7%) | -$62.78 M(+12.3%) |
| Jun 2021 | - | -$16.60 M(-1310.2%) | -$55.90 M(+4.6%) |
| Mar 2021 | - | $1.37 M(-104.7%) | -$53.42 M(-11.5%) |
| Dec 2020 | -$60.34 M(+170.9%) | -$29.17 M(+153.7%) | -$60.34 M(+66.9%) |
| Sep 2020 | - | -$11.50 M(-18.6%) | -$36.14 M(+48.7%) |
| Jun 2020 | - | -$14.12 M(+154.9%) | -$24.30 M(+139.5%) |
| Mar 2020 | - | -$5.54 M(+11.3%) | -$10.15 M(+188.3%) |
| Dec 2019 | -$22.27 M | -$4.98 M(-1569.6%) | -$3.52 M(-288.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $338.80 K(+862.5%) | $1.87 M(+12.0%) |
| Jun 2019 | - | $35.20 K(-96.8%) | $1.67 M(-39.2%) |
| Mar 2019 | - | $1.09 M(+165.5%) | $2.75 M(+16.8%) |
| Dec 2018 | -$14.59 M(+6138.7%) | - | - |
| Dec 2018 | - | $409.10 K(+194.7%) | $2.35 M(+174.3%) |
| Sep 2018 | - | $138.80 K(-87.5%) | $857.30 K(-34.9%) |
| Jun 2018 | - | $1.11 M(+60.9%) | $1.32 M(+220.0%) |
| Mar 2018 | - | $691.10 K(-163.7%) | $411.80 K(-247.4%) |
| Dec 2017 | - | -$1.08 M(-281.1%) | -$279.30 K(-134.7%) |
| Sep 2017 | - | $599.10 K(+190.1%) | $805.60 K(+290.1%) |
| Jun 2017 | - | $206.50 K | $206.50 K |
| Dec 2016 | -$233.80 K(+225.6%) | - | - |
| Dec 2015 | -$71.80 K(-38.2%) | - | - |
| Dec 2014 | -$116.20 K(-82.8%) | - | - |
| Dec 2013 | -$676.80 K(+285.6%) | - | - |
| Dec 2012 | -$175.50 K(+9.2%) | - | - |
| Dec 2011 | -$160.70 K(-80.1%) | - | - |
| Dec 2010 | -$806.50 K(+106.5%) | - | - |
| Dec 2009 | -$390.50 K(+969.9%) | - | - |
| Dec 2008 | -$36.50 K | - | - |
FAQ
- What is Cullinan Oncology annual earnings before interest & taxes?
- What is the all time high annual EBIT for Cullinan Oncology?
- What is Cullinan Oncology annual EBIT year-on-year change?
- What is Cullinan Oncology quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Cullinan Oncology?
- What is Cullinan Oncology quarterly EBIT year-on-year change?
- What is Cullinan Oncology TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Cullinan Oncology?
- What is Cullinan Oncology TTM EBIT year-on-year change?
What is Cullinan Oncology annual earnings before interest & taxes?
The current annual EBIT of CGEM is -$190.65 M
What is the all time high annual EBIT for Cullinan Oncology?
Cullinan Oncology all-time high annual earnings before interest & taxes is -$36.50 K
What is Cullinan Oncology annual EBIT year-on-year change?
Over the past year, CGEM annual earnings before interest & taxes has changed by -$58.51 M (-44.28%)
What is Cullinan Oncology quarterly earnings before interest & taxes?
The current quarterly EBIT of CGEM is -$48.85 M
What is the all time high quarterly EBIT for Cullinan Oncology?
Cullinan Oncology all-time high quarterly earnings before interest & taxes is $1.37 M
What is Cullinan Oncology quarterly EBIT year-on-year change?
Over the past year, CGEM quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is Cullinan Oncology TTM earnings before interest & taxes?
The current TTM EBIT of CGEM is -$187.36 M
What is the all time high TTM EBIT for Cullinan Oncology?
Cullinan Oncology all-time high TTM earnings before interest & taxes is $2.75 M
What is Cullinan Oncology TTM EBIT year-on-year change?
Over the past year, CGEM TTM earnings before interest & taxes has changed by $0.00 (0.00%)